Loss of α-1,2-mannosidase MAN1C1 promotes tumorigenesis of intrahepatic cholangiocarcinoma through enhancing CD133-FIP200 interaction
Cell Reports · 2023
DOI: 10.1016/j.celrep.2023.113588 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Yuanyan Wei und 10 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Glycoconjuates Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, …. Hauptthemen laut MEDLINE: Bile Duct Neoplasms, Cholangiocarcinoma. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanghai Municipality Science and Technology Commission, Servier, Natural Science Foundation of Shanghai Municipality.
Abstract (Originalsprache)
CD133 is widely used as a marker to isolate tumor-initiating cells in many types of cancers. The structure of N-glycan on CD133 is altered during the differentiation of tumor-initiating cells. However, the relationship between CD133 N-glycosylation and stem cell characteristics remains elusive. Here, we found that the level of α-1,2-mannosylated CD133 was associated with the level of stemness genes in intrahepatic cholangiocarcinoma (iCCA) tissues. α-1,2-mannosylated CD133+ cells possessed the characteristics of tumor-initiating cells. The loss of the Golgi α-mannosidase I coding gene MAN1C1 resulted in the formation of α-1,2-mannosylated CD133 in iCCA-initiating cells. Mechanistically, α-1,2-mannosylation promoted the cytoplasmic distribution of CD133 and enhanced the interaction between CD133 and the autophagy gene FIP200, subsequently promoting the tumorigenesis of α-1,2-mannosylated CD133+ cells. Analysis of iCCA samples showed that the level of cytoplasmic CD133 was associated with poor iCCA prognosis. Collectively, α-1,2-mannosylated CD133 is a functional marker of iCCA-initiating cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory of Glycoconjuates Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, P.R. China. Electronic address: yywei@fudan.edu.cn.
- NHC Key Laboratory of Glycoconjuates Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, P.R. China.
- Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai 200032, P.R. China; Ke…
- NHC Key Laboratory of Glycoconjuates Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, P.R. China. Electronic address: jianhaijiang@fudan.ed…
Förderung
- Shanghai Municipality Science and Technology Commission
- Servier
- Natural Science Foundation of Shanghai Municipality
- Fudan University
- National Natural Science Foundation of China
Zitieren
APA
Wei, Y., Chen, Q., Chen, J., Zhou, C., Geng, S., Shi, D., Huang, S., Liang, Z., Chen, X., Ren, N., & Jiang, J. (2023). Loss of α-1,2-mannosidase MAN1C1 promotes tumorigenesis of intrahepatic cholangiocarcinoma through enhancing CD133-FIP200 interaction. Cell Reports. https://doi.org/10.1016/j.celrep.2023.113588
Vancouver
Wei Y, Chen Q, Chen J, Zhou C, Geng S, Shi D, et al. Loss of α-1,2-mannosidase MAN1C1 promotes tumorigenesis of intrahepatic cholangiocarcinoma through enhancing CD133-FIP200 interaction. Cell Reports. 2023. doi:10.1016/j.celrep.2023.113588
BibTeX
@article{Wei2023,
author = {Wei, Yuanyan and Chen, Qihang and Chen, Jiayue and Zhou, Chenhao and Geng, Shuting and Shi, Danfang and Huang, Sijing and Liang, Zhiwei and Chen, Xiaoning and Ren, Ning and Jiang, Jianhai},
title = {Loss of α-1,2-mannosidase MAN1C1 promotes tumorigenesis of intrahepatic cholangiocarcinoma through enhancing CD133-FIP200 interaction},
journal = {Cell Reports},
year = {2023},
doi = {10.1016/j.celrep.2023.113588}
}
EUVIMED